BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26781558)

  • 1. Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.
    Graham RN; Baldwin DR; Callister ME; Gleeson FV
    Br J Radiol; 2016; 89(1059):20150776. PubMed ID: 26781558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
    Callister ME; Baldwin DR; Akram AR; Barnard S; Cane P; Draffan J; Franks K; Gleeson F; Graham R; Malhotra P; Prokop M; Rodger K; Subesinghe M; Waller D; Woolhouse I; ;
    Thorax; 2015 Aug; 70 Suppl 2():ii1-ii54. PubMed ID: 26082159
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of pulmonary nodules according to the 2015 British Thoracic Society guidelines. Key messages for clinical practice.
    Baldwin DR
    Pol Arch Med Wewn; 2016 Apr; 126(4):262-74. PubMed ID: 27121867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management strategy of pulmonary nodule in 2013.
    Lederlin M; Revel MP; Khalil A; Ferretti G; Milleron B; Laurent F
    Diagn Interv Imaging; 2013 Nov; 94(11):1081-94. PubMed ID: 24034970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Guidelines for the Management of Pulmonary Nodules: Toward Better Implementation.
    Baldwin DR
    Chest; 2015 Dec; 148(6):1365-1367. PubMed ID: 26621288
    [No Abstract]   [Full Text] [Related]  

  • 6. How should pulmonary nodules be optimally investigated and managed?
    Callister ME; Baldwin DR
    Lung Cancer; 2016 Jan; 91():48-55. PubMed ID: 26711934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsolid pulmonary nodule management and lung adenocarcinoma classification: state of the art and future trends.
    Godoy MC; Truong MT; Sabloff B; Naidich DP
    Semin Roentgenol; 2013 Oct; 48(4):295-307. PubMed ID: 24034262
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary nodule characterization, including computer analysis and quantitative features.
    Bartholmai BJ; Koo CW; Johnson GB; White DB; Raghunath SM; Rajagopalan S; Moynagh MR; Lindell RM; Hartman TE
    J Thorac Imaging; 2015 Mar; 30(2):139-56. PubMed ID: 25658478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules.
    Baldwin DR; Callister ME;
    Thorax; 2015 Aug; 70(8):794-8. PubMed ID: 26135833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pulmonary nodules in head and neck cancer patients - Our experience and interpretation of the British Thoracic Society Guidelines.
    Green R; King M; Reid H; Murchison JT; Evans A; Nixon IJ
    Surgeon; 2017 Aug; 15(4):227-230. PubMed ID: 27838234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
    Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
    Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the ground-glass nodule.
    Detterbeck FC; Homer RJ
    Clin Chest Med; 2011 Dec; 32(4):799-810. PubMed ID: 22054887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream Costs Associated with Incidental Pulmonary Nodules Detected on CT.
    Rosenkrantz AB; Xue X; Gyftopoulos S; Kim DC; Nicola GN
    Acad Radiol; 2019 Jun; 26(6):798-802. PubMed ID: 30093215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
    Tanner NT; Aggarwal J; Gould MK; Kearney P; Diette G; Vachani A; Fang KC; Silvestri GA
    Chest; 2015 Dec; 148(6):1405-1414. PubMed ID: 26087071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of the Fleischner Society Guidelines to Chest CT Examination Interpretive Reports Improves Adherence to Recommended Follow-up Care for Incidental Pulmonary Nodules.
    McDonald JS; Koo CW; White D; Hartman TE; Bender CE; Sykes AG
    Acad Radiol; 2017 Mar; 24(3):337-344. PubMed ID: 27793580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of an incidentally discovered pulmonary nodule.
    Beigelman-Aubry C; Hill C; Grenier PA
    Eur Radiol; 2007 Feb; 17(2):449-66. PubMed ID: 17021707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
    Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
    Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.